Work

Authors' reply to comment What should be the endpoints of a symptomatic drug and its control?

Year: 2017

Type: letter

Source: The Lancet Haematology

DOI: 10.1016/s2352-3026(17)30195-3

Authors: Ruben Mesa, Claire Harrison

Institutions: Mayo Clinic, Mayo Clinic in Arizona, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2766411410

Cites: 5

Cited by: 1

Related to: 10